Damodar Krishnabahadur Thappa

Title: The Innovations of Damodar Krishnabahadur Thappa

Introduction

Damodar Krishnabahadur Thappa is a notable inventor based in Mumbai, India. He has made significant contributions to the field of biotechnology, particularly in the production of insulin and recombinant proteins. With a total of four patents to his name, Thappa's work has the potential to impact the medical and pharmaceutical industries significantly.

Latest Patents

Thappa's latest patents include a groundbreaking process for the production of insulin and insulin analogues. This process involves the expression of insulin or insulin analogs through an expression vector in a host cell. The expression vector is designed to include a leader peptide, a nucleotide sequence encoding an affinity tag, and a cleavage site, all of which are crucial for the efficient production of insulin. Another notable patent is an expression vector for the production of recombinant proteins in prokaryotic host cells. This innovation also utilizes a nucleotide sequence encoding for a leader peptide, showcasing Thappa's expertise in genetic engineering.

Career Highlights

Thappa is currently employed at Biogenomics Limited, where he continues to advance his research and development efforts. His work at the company focuses on innovative solutions in biotechnology, particularly in the area of protein production. His contributions have been instrumental in enhancing the efficiency and effectiveness of biopharmaceutical manufacturing processes.

Collaborations

Thappa has collaborated with several professionals in his field, including Archana Rajesh Krishnan and Sanjay M Sonar. These collaborations have fostered a productive environment for innovation and have led to the successful development of new technologies in biotechnology.

Conclusion

Damodar Krishnabahadur Thappa's contributions to the field of biotechnology are noteworthy and impactful. His patents in insulin production and recombinant proteins demonstrate his commitment to advancing medical science. Through his work at Biogenomics Limited and collaborations with other professionals, Thappa continues to push the boundaries of innovation in his field.